 Home > Active Ingredient News > Antitumor Therapy > Lancet Oncol: Can cancer patients get the new crown vaccine?

Lancet Oncol: Can cancer patients get the new crown vaccine?

 Last Update: 2021-05-08
 Source: Internet
 Author: User

Tags

cancer poop

peritoneal fluid analysis

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

At present, China is vigorously promoting the new crown pneumonia vaccination, not only free of charge, but even some areas have begun to vaccinate to send edible oil or Starbucks coffee (choose one).

Can patients with new coronary pneumonia cancer be vaccinated against new coronary pneumonia? Can cancer patients be vaccinated against new coronary pneumonia vaccine?

There are no clear data on the effectiveness and safety of the new coronary pneumonia vaccine in cancer patients.

The Lancet Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study COVID-19 immunity

The study is a prospective observational study.

A total of 151 cancer patients (95 solid tumors, 56 hematological tumors) and 54 healthy controls were recruited.

Immunogenicity of BNT162b2 vaccine

Sixteen healthy controls, 25 patients with solid tumors, and 6 patients with hematological tumors received the second dose of vaccine on day 21.

100% of healthy controls (12/12), 95% of patients with solid tumors (18/19), and 60% (3/5) of patients with hematological tumors have positive sera

Serological response of BNT162b2 vaccine

The vaccine is well tolerated .

The vaccine is well tolerated.

For cancer patients, a dose of BNT162b2 vaccine is not effective.

Original source:

Leticia Monin, et al.

org/10.
1016/S1470-2045(21)00213-8" target="_blank" rel="noopener">Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study in this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.